Growth Metrics

Vivos (RDGL) Net Cash Flow (QoQ) (2010 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Vivos - - -3,105.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -17.87%
Sep 30, 2025 24.16%
Jun 30, 2025 -157.43%
Mar 31, 2025 5.85%
Dec 31, 2024 296.42%
Sep 30, 2024 -243.18%
Jun 30, 2024 259.66%
Mar 31, 2024 -499.43%
Dec 31, 2023 126.16%
Sep 30, 2023 32.58%
Jun 30, 2023 -7.05%
Mar 31, 2023 -4.25%
Dec 31, 2022 0.46%
Sep 30, 2022 -65.37%
Jun 30, 2022 55.47%
Mar 31, 2022 -1.01%
Dec 31, 2021 -113.65%
Sep 30, 2021 48.71%
Jun 30, 2021 -121.59%
Mar 31, 2021 80.94%
Dec 31, 2020 479.94%
Sep 30, 2020 -195.93%
Jun 30, 2020 1,685.82%
Mar 31, 2020 88.87%
Dec 31, 2019 -192.08%
Sep 30, 2019 550.73%
Jun 30, 2019 -191.71%
Mar 31, 2019 560.63%
Jun 30, 2018 99.81%
Mar 31, 2018 39.82%
Dec 31, 2017 96.03%
Sep 30, 2017 -200.46%
Jun 30, 2017 8,353.71%
Mar 31, 2017 99.87%
Dec 31, 2016 -199.16%
Sep 30, 2016 1,428.53%
Jun 30, 2016 -459.56%
Mar 31, 2016 -59.85%
Dec 31, 2015 1,011.26%
Sep 30, 2015 -179.32%
Jun 30, 2015 940.58%
Mar 31, 2015 808.70%
Dec 31, 2014 99.74%
Sep 30, 2014 -471.17%
Jun 30, 2014 -63.33%
Mar 31, 2014 449.49%
Dec 31, 2013 -236.32%
Sep 30, 2013 131.78%
Jun 30, 2013 -199.06%
Mar 31, 2013 249.16%
Dec 31, 2012 -222.16%
Sep 30, 2012 5,964.74%
Jun 30, 2012 101.41%
Mar 31, 2012 -215.81%
Dec 31, 2011 150.78%
Sep 30, 2011 110.58%
Jun 30, 2011 72.01%
Mar 31, 2011 74.38%
Dec 31, 2010 -453.10%